Trump Administration Announces New Plan to Cap Insulin Costs in Medicare

High drug prices have been a focus of Congress and the Trump Administration for the past year, with insulin becoming the prime example of the negative impact increasing drug prices are having on patients. The Endocrine Society has made addressing the high cost of insulin a priority for the past three years.  We have urged […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:

Share this article